Four Points Innovation

Four Points Innovation is a private translational drug discovery company launched in 2019 by Duke University and Deerfield Management to accelerate the preclinical development of new therapeutics. The company supports Duke research projects with funding, development expertise, and commercialization support, with Deerfield committing up to $130 million over the collaboration term. Its mandate is broad rather than centered on a single disclosed product pipeline, and it welcomes proposals across therapeutic areas, including hard-to-treat and rare diseases. Four Points functions primarily as an innovation and venture-enabling vehicle that helps advance promising academic discoveries toward clinically relevant therapeutics and potential spinout formation.